Simon Spichak

3 days ago | health.com | Simon Spichak |Julia Landwehr |Nick Blackmer

Kinga Krzeminska / Getty ImagesHospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but can be serious, a new study foundCompounded versions of semaglutide could explain some of these visits, since these drugs are not FDA-regulated and could cause dosing errors. Side effects can usually be managed at home, but there are some signs that might indicate you should seek care at an emergency room, experts said.

1 week ago | beingpatient.com | Simon Spichak

The drugmakers behind Leqembi and Kisunla didn’t clue participants in if they had a higher risk of side effects during these drugs’ clinical trials. But now that the link between side effects and genetic risk is clearer cut, have companies started disclosing these risks? Being Patient investigated. Your genetics could make you more vulnerable to the side effects of the new class of Alzheimer’s drugs.

1 week ago | beingpatient.com | Simon Spichak

New research shows the Alzheimer’s protein tau builds up faster in women’s brains. Could this help scientists explain why women are twice as likely to develop Alzheimer’s? Years before any symptoms of Alzheimer’s appear, beta-amyloid and tau proteins misfold, tangle, and aggregate inside the brain.

2 weeks ago | beingpatient.com | Simon Spichak

People who start developing Alzheimer’s before they hit 65 can run into roadblocks with private insurers that refuse to cover diagnostic scans and treatments. State legislators have introduced bills that would make these insurers pay. Before Americans become eligible for Medicare at 65, they often rely on private insurance.

3 weeks ago | beingpatient.com | Simon Spichak

UNLV researcher Jace Flatt has studied cognitive decline and dementia risk in LGBTQ+ Americans for over a decade. Here’s what his team learned in research which was recently defunded in line with the federal government’s ban on diversity, equity, and inclusion. Loneliness, heart disease, diabetes, and mental health conditions all put older Americans at a higher risk of developing cognitive decline and Alzheimer’s disease.